The INVEST Digital Health conference at Pegasus Park in Dallas provided an ideal setting for healthcare startups to exhibit their ambitious tech offerings. The conference attracted healthcare executives and investors for conversations around topics such as direct-to-consumer diagnostics and consumer drug platforms. It was against this backdrop that three companies shared the healthcare challenges their technologies seek to remedy in interviews with MedCity News Editor-in-Chief Arundhati Parmar and Reporter Marissa Plescia.
SequestBio
One of the biggest challenges in oncology drug development is figuring out which patients will get the most benefit from one drug compared with another. SequestBio uses blood and tumor samples from patients to create a digital twin to predict how a patient may respond to different types of treatments. SequestBio COO Arvin Honari described how the technology works to Plescia.
PixCare
PixCare’s vision involves converting a smartphone into a diagnostic device to avoid needless pediatrician appointments. There are approximately 20 million pediatrician visits per year for sore throats in children, yet only 20% to 30% of these cases are actually strep throat, according to Raj Shekhar, PhD, PixCare Founder and CTO. In an interview, Shekhar, joined by Youness Arjoune, PhD, Chief AI Officer, explained to Parmar that the goal is for the device to be used in conjunction with a telemedicine visit.
Paytient
Affordability was a hot topic in the midterm elections and continues to be an important issue in healthcare. Dr. Trent Haywood, Chief Outcomes Officer with Paytient, explained to Parmar how the company works with payers and self-insured employers to develop payment plans so people won’t put off important medical and pharmacy needs.
Photo: Urupong, Getty Images